Leading brokers name 3 ASX shares to sell today

Leading brokers have named AGL Energy Limited (ASX:AGL) and these ASX shares as sells this week. Here's why they are bearish…

On Monday I looked at three ASX shares that brokers have given buy ratings to this week.

Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.

Here's why these brokers are bearish on these ASX shares:

Model bear in front of falling line graph, cheap stocks, cheap ASX shares

Image source: Getty Images

AGL Energy Limited (ASX: AGL)

According to a note out of UBS, its analysts have downgraded this energy company's shares to a sell rating and cut the price target on them to $12.25. The broker made the move after reducing its forecasts to account for margin pressures from lower wholesale electricity prices. It also has concerns over the shift to renewable energy and AGL's reliance of coal for its electricity generation. Combined, it is expecting the company's earnings to fall consistently over the coming years. The AGL share price is trading at $12.92 on Tuesday.

OZ Minerals Limited (ASX: OZL)

A note out of Goldman Sachs reveals that its analysts have retained their sell rating but lifted the price target on this copper producer's shares to $16.70. The broker believes that OZ Minerals' shares are overvalued at 1.2x net asset value. This compares to the sector average of 1x net asset value. It feels this is being caused partly by investors overvaluing the company's Carrapateena mine. It notes that its  share price implies a value for the asset in line with the larger and higher quality Olympic Dam mine owned by BHP Group Ltd (ASX: BHP). The OZ Minerals share price is fetching $18.52 this afternoon.

Virtus Health Ltd (ASX: VRT)

Analysts at Morgan Stanley have downgraded this fertility treatment company's shares to an underweight rating but increased the price target on them to $4.90. The broker made the move on the belief that Virtus Health's shares are overvalued after a very strong gain in recent months. Morgan Stanley also has concerns about a long term shift to lower-value IVF services. The Virtus Health share price is trading at $5.44 today.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Virtus Health Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ASX Share Market News

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
ASX Share Market News

ASX 200 mining shares smashed in major market sell-off

The ASX 200 fell 5.39% amid a mining sell-off, with BHP shares tumbling almost 13% last week.

Read more »

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »